Advantages and drawbacks of in vitro Interferon-γ/T cell assays compared to the Mantoux test for the diagnosis of tuberculosis;Avantages et limites des tests sanguins in vitro lymphocytes T/interféron gamma comparativement au test intradermique à la tuberculine pour le diagnostic de tuberculose{star, open}

Archives de Pediatrie

Volumn 14, Issue 2, 2007, Pages 207-211

  Herrmann, J L ^a,b   Simonney, N ^a   Lagrange, P H ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Diagnosis; Interferon ; Mantoux test; Quantiferon TB Gold; T cell assays; T SPOT.TB; Tuberculosis

Indexed keywords

BCG VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6;

ARTICLE; CELL ASSAY; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33846781646     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2006.11.008     Document Type: Article

References (15)

1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am. J. Respir. Crit. Care Med. 161 (2000) S221-S247
2. Ferebee S.H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Adv. Tuberc. Res. 17 (1969) 29-106
3. Brosch R., Gordon S.V., Marmiesse M., et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99 (2002) 3684-3689
4. Andersen P., Munk M.E., Pollock J.M., et al. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
5. Richeldi L. An update on the diagnosis of tuberculosis infection. Am. J. Respir. Crit. Care Med. 174 (2006) 736-742
6. Mazurek G.H., Jereb J., Lobue P., et al. Guidelines for using the Quanti-FERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54 (2005) 49-55
7. Pai M., Riley L.W., and Colford Jr. J.M. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4 (2004) 761-776
8. Huebner R.E., Schein M.F., and Bass Jr. J.B. The tuberculin skin test. Clin. Infect. Dis. 17 (1993) 968-975
9. Ravn P., Munk M.E., Andersen A.B., et al. Prospective evaluation of whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin. Diagn. Lab. Immunol. 12 (2005) 491-496
10. Ferrara G., Losi M., D'Amico R., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
11. Lee J.Y., Choi H.J., Park I.N., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur. Respir. J. 28 (2006) 24-30
12. Connell T.G., Curtis N., Ranganathan S.C., et al. Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium in children. Thorax 61 (2006) 616-620
13. Nicol M.P., Pienaar D., Wood K., et al. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin. Infect. Dis. 40 (2005) 1301-1308
14. Lambert L., Rajbhandary S., Quails N., et al. Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect. Control Hosp. Epidemiol. 24 (2003) 814-820
15. Che D., and Bitar D. Les cas de tuberculose en France en 2003. Bull Epidemiol Hebd 17 (2005) 66-69